Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein

British Journal of Pharmacology

Volumn 118, Issue 3, 1996, Pages 643-648

  Barker, J E ^a,d   Bakhle, Y S ^b   Anderson, J ^c   Treasure, T ^c   Piper, P J ^e  

^a ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e NONE

Author keywords

Angiotensin II; Human saphenous vein; Nitric oxide; Prostacyclin

Indexed keywords

ANGIOTENSIN; CYCLIC GMP; GLYCERYL TRINITRATE; ILOPROST; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PIROXICAM; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR; VASODILATOR AGENT;

ARTICLE; CONTROLLED STUDY; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SAPHENOUS VEIN; VASOCONSTRICTION; VASODILATATION;

EID: 0030010575     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15449.x     Document Type: Article

References (27)

1. 4 on human isolated saphenous vein. Br. J. Clin. Pharmacol., 34, 409-414.
2. ANGELINI, G.D., BECKENBRIDGE, I.M., PSAILA, J.V., WILLIAMS, H.M., HENDERSON, A.H. & NEWBY, A.C. (1987). Preparation of human saphenous vein for coronary artery bypass grafting impairs its capacity to produce prostacyclin. Cardiovasc. Res., 21, 28-33.
3. ANGELINI, G.D., CHRISTIE, M.L. BRYAN, A.J. & LEWIS, M.J. (1989). Surgical preparation impairs release of endothelium-derived relaxing factor from human saphenous vein. Ann. Thorac Surg., 48, 417-420.
4. ANGELINI, S.D., SOYOMBO, A.A. & NEWBY, A.C. (1991). Smooth muscle cell proliferation in response to injury in an organ culture of human saphenous vein. Eur. J. Vasc. Surg., 5, 5-12.
5. BARKER, J.E., ANDERSON, J., TREASURE, T. & PIPER, P.J. (1994a). Influence of endothelium and surgical preparation on responses of the human saphenous vein and internal thoracic artery to angiotensin II. Br. J. Clin. Pharmacol., 38, 57-62.
6. BARKER, J.E., ANDERSON, J., TREASURE, T. & PIPER, P.J. (1994b). Effects of prostaglandins on angiotensin II stimulated release of nitric oxide in the human saphenous vein. Br. J. Pharmacol., 112, 446P.
7. BATTISTINI, B., BOTTING, R.R. & BAKHLE, Y.S. (1994). COX-1 and COX-2; towards the development of more selective NSAIDs. Drugs New Perspectives, 8, 501-512.
8. DONI, M.G. WHITTLE, B.J.R. & MONCADA, S. (1988). Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur. J. Pharmacol., 151, 19-25.
9. GREUTTER, C.A., RYAN, E.T., LEMKE, S.M., BAILY, D.A., FOX, M.K. & SCHOEPP, D.D. (1987). Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels. Eur. J. Pharmacol., 146, 85-95.
10. GROSS, S.S., HATTORI, Y. & VANE, J.R. (1994). Cyclic AMP stimulates the induction of nitric oxide synthase by immunostimulants in vascular smooth muscle. In The Biology of Nitric Oxide, Vol 3, pp. 260-264. ed. Moncada, S., Feelisch, M., Busse, R. & Higgs, E.A. London and Chapel Hill: Portaland Press.
11. 2 production by vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 194, 420-424.
12. G-nitro-L-arginine methyl ester in the porcine isolated splenic artery are sensitive to lipoxygenase inhibitors. Naunyn Schmied. Arch. Pharmacol., 347, 115-118.
13. MAROTTA, P., SAUTEBIN, L. & DI ROSA, M. (1992). Modulation of induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br. J. Pharmacol., 107, 640-641.
14. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide; physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
15. 2 and prostacyclin. Pharmacol. Rev., 30, 293-331.
16. NAKAMURA, M. & BAKHLE, Y.S. (1991). Effects of ph CL 28A on eicosanoid synthesis in rat isolated heart. Prostaglandins, 42, 303-311.
17. PAINTER, T.A. (1990). Myointimal hyperplasia; pathogenesis and implications. Artif. Organs, 15, 42-55.
18. RAPOPORT, R.M. & MURAD, F. (1983). Endothelium-dependent nitrovasodilator induced relaxation of vascular smooth muscle; role for cGMP. J. Cycl. Nucl. Prot. Phosphor. Res., 9, 281.
19. SALVEMINI, D., MISKO, T.P., MASFERRER, J.L., SEIBERT, K., CURRIE, M.G. & NEEDLEMAN, P. (1993). Nitric oxide activates cyclo-oxygenase enzymes. Proc. Natl. Acad. Sci. U.S.A., 90, 7240-7244.
20. SAUTEBIN, L., IALENTI, A., IANARO, A. & DI ROSA, M. (1995). Modulation by nitric oxide synthase of prostaglandin biosynthesis in the rat. Br. J. Pharmacol., 114, 323-328.
21. SCHINI, V., SCHOEFFTER, P. & MILLER, R.C. (1989). Effect of endothelium on basal and stimulated accumulation and efflux of cyclicGMP in rat isolated aorta. Br. J. Pharmacol., 97, 853-865.
22. SWIERKOSZ, T.A., MITCHELL, J.A., WARNER, T.D., BOTTING, R.M. & VANE, J.R. (1995). Co-induction of nitric oxide synthase and cyclo-oxygenase; interactions between nitric oxide and prostanoids. Br. J. Pharmacol., 114, 1335-1342.
23. TAYLOR, K.M., MORTON, I.J., BROWN, J.J., BAIN, W.H. & CAVES, P. (1977). Hypertension and the renin-angiotensin system following open-heart surgery. J. Thorac. Cardiovasc. Surg., 74, 840-845.
24. TODA, N. & MIYAZAKI, M. (1981). Angiotensin-induced relaxation in isolated dog renal and cerebral arteries. Am. J. Physiol., 240, H247-H254.
25. VALLOTTON, M.B., GERBER-WICHT, C., DOLCI, W. & RIVEST, R.W. (1990). Effect of different calcium channel blockers on angiolensin II- and vasopressin-induced prostacyclin biosynthesis in vascular smooth muscle cells. J. Cardiovasc. Pharmacol., 15, 598-603.
26. YAMAZAKI, M. & TODA, N. (1991). Comparison of responses to angiotensin II of dog mesenteric arteries and veins. Eur. J. Pharmacol., 201, 223-229.
27. YANG, Z., DIEDERICH, D., SCHNEIDER, R., SIEBERNMANN, R., STULZ, P., VON SEGESSER, I., TURINA, F.R., BUHLER, F.R. & LUSCHER, T.F. (1989). Endothelium-derived relaxing factor and protection against contractions induced by histamine and serotonin in the human mammary artery and saphenous vein. Circulation, 80, 1041-1048.